Sigma Labs Releases Alpha Version of Its OEM Developer’s Kit for PrintRite3D®
Apr 05, 2017 12:01 pm UTC| Business
SANTA FE, N.M., April 05, 2017 -- Sigma Labs, Inc. (NASDAQ:SGLB) (“Sigma Labs” or the “Company”), a provider of quality assurance software under the PrintRite3D® brand, today announced the release of its OEM Developer's...
Fortress Biotech Announces Orphan Drug Designations for CAEL-101 in Amyloidosis
Apr 05, 2017 12:01 pm UTC| Business
NEW YORK, April 05, 2017 -- Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today...
Fortress Biotech Announces Orphan Drug Designations for CAEL-101 in Amyloidosis
Apr 05, 2017 12:01 pm UTC| Business
NEW YORK, April 05, 2017 -- Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today...
Apr 05, 2017 12:01 pm UTC| Business
CARLSBAD, Calif., April 05, 2017 -- MaxLinear, Inc.(NYSE:MXL), a leading provider of integrated radio frequency and mixed-signal integrated circuits for the connected home and wired and wireless infrastructure markets,...
Apr 05, 2017 12:01 pm UTC| Business
CARLSBAD, Calif., April 05, 2017 -- MaxLinear, Inc.(NYSE:MXL), a leading provider of integrated radio frequency and mixed-signal integrated circuits for the connected home and wired and wireless infrastructure markets,...
Apr 05, 2017 12:00 pm UTC| Business
Combining ComPACT DNA electroporation and cellular vaccination led to increased tumor antigen-specific CD8+ T cells, delayed tumor progression and improved overall survival in preclinical models ...
Apr 05, 2017 12:00 pm UTC| Business
SEATTLE, April 05, 2017 -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced data highlights from presentations of preclinical data for the Company’s investigational...